| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 14, 2020 | BHC Bausch Health Companies Inc. | Paulson John52 | Director | Buy | 5,000,000 | $16.65 | $83,251,535.68 | +1.8% | |
| May 13, 2020 | COLL Collegium Pharmaceutical, Inc | Dreyer Scott54 | EVP &Chief Commercial Officer | Sell | 4,434 | $22.61 | $100,252.74 | -8.4% | |
| May 13, 2020 | COLL Collegium Pharmaceutical, Inc | Heffernan Michael Thomas | Director | Sell | 19,254 | $21.63 | $416,421.29 | -6.7% | |
| May 13, 2020 | ALKS Alkermes Plc. | Brown Iain Michael | SVP Finance &CAO, Alks Inc. | Sell | 6,250 | $15.39 | $96,193.13 | -13.9% | |
| May 13, 2020 | COLL Collegium Pharmaceutical, Inc | Fleming Alison B | Chief Technology Officer | Sell | 7,989 | $21.67 | $173,147.04 | -3.7% | |
| May 12, 2020 | EBS Emergent Biosolutions Inc. | Zoon Kathryn C62 | Director | Sell | 1,660 | $85.21 | $141,454.24 | -10.1% | |
| May 12, 2020 | NBIX Neurocrine Biosciences Inc | Bozigian Haig P. | Chief Development Officer | Sell | 61,555 | $114.94 | $7,075,396.39 | -9.4% | |
| May 12, 2020 | AMPH Amphastar Pharmaceuticals, Inc. | Prins Richard K61 | Director | Sell | 30,282 | $19.00 | $575,418.56 | -43.5% | |
| May 12, 2020 | AMPH Amphastar Pharmaceuticals, Inc. | Zasloff Michael A53 | Director | Sell | 10,000 | $19.00 | $190,000.00 | -22.1% | |
| May 12, 2020 | PBH Prestige Consumer Healthcare Inc. | Lombardi Ronald M.52 | Chief Executive Officer | Sell | 29,593 | $40.00 | $1,183,720.00 | -16.6% | |
| May 12, 2020 | ALKS Alkermes Plc. | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sell | 18,000 | $15.75 | $283,469.40 | -8.2% | |
| May 12, 2020 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 100 | $19.20 | $1,920.00 | -0.1% | |
| May 11, 2020 | IRWD Ironwood Pharmaceuticals Inc | Rickard Jason65 | SVP, Chief Operating Officer | Sell | 510 | $10.35 | $5,278.50 | -0.2% | |
| May 11, 2020 | IRWD Ironwood Pharmaceuticals Inc | MacDonald Kelly | Chief Accounting Officer | Sell | 1,153 | $10.35 | $11,933.55 | -0.5% | |
| May 11, 2020 | EBS Emergent Biosolutions Inc. | Joulwan George A | Director | Sell | 2,000 | $85.19 | $170,371.20 | -6.3% | |
| May 11, 2020 | LFCR Lifecore Biomedical, Inc. \de\ | Obus Nelson | Director | Buy | 5,000 | $10.80 | $54,000.00 | +0.2% | |
| May 11, 2020 | IRWD Ironwood Pharmaceuticals Inc | Mallon Mark | Chief Executive Officer | Sell | 23,206 | $10.35 | $240,182.10 | -4.4% | |
| May 11, 2020 | EBS Emergent Biosolutions Inc. | Harsanyi Zsolt | Director | Sell | 4,940 | $81.99 | $405,024.67 | -16.5% | |
| May 11, 2020 | IRWD Ironwood Pharmaceuticals Inc | Kilroy Conor | SVP, GC &Secretary | Sell | 716 | $10.35 | $7,410.60 | -0.3% | |
| May 11, 2020 | IRWD Ironwood Pharmaceuticals Inc | McCourt Thomas A66 | President | Sell | 1,697 | $10.35 | $17,563.95 | -0.5% | |
| May 8, 2020 | SUPN Supernus Pharmaceuticals, Inc. | Patrick Gregory S | Sr VP, Chief Financial Officer | Sell | 15,000 | $23.14 | $347,034.00 | -24.6% | |
| May 8, 2020 | AQST Aquestive Therapeutics, Inc. | Schobel Alexander Mark83 | Chief Innovation/ Tech Officer | Sell | 40,000 | $5.00 | $200,000.00 | -4.2% | |
| May 7, 2020 | PRGO Perrigo Co Plc | Farrington Thomas | EVP And CIO | Sell | 2,000 | $52.13 | $104,254.17 | -3.5% | |
| May 7, 2020 | NBIX Neurocrine Biosciences Inc | Abernethy Matt57 | Chief Financial Officer | Sell | 15,000 | $110.21 | $1,653,133.50 | -71.6% | |
| May 7, 2020 | MRK Merck & Co., Inc. | Brun Leslie A | Director | Sell | 5,000 | $75.46 | $377,300.00 | -72.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.